DAY 1: JAN 12, 2017
8:00 AM Inauguration and Opening speech
Dr Surapol Issaragrisil (President, APHCON); Dr Richard Champlin; Dr. Wichai Prayoonwiwat (President, Thai Society Hematology)
8:30 AM: B-CELL LYMPHOMA
Moderator: Surapol Issaragrisil (Thailand); Richard Champlin (USA)
Revised Classification, New Diagnostic Criteria for Non Hodgkin's Lymphoma
Pei Lin (USA) (20 min)
Allogeneic Stem Cell transplantation for Lymphoma (includes Hodgkin's Lymphoma)
Didier Blaise (France) (30 min)
Antibodies, Protein Inhibitors and CAR-T Updates from ASH 2016
Frederick Hagemeister (USA) (30 min)
10:00 AM: Coffee Break and Poster viewing
10:30 AM: T-CELL LYMPHOMA
Moderator: Wichai Prayoonwiwat (Thailand), Adolfo de la Fuente (Spain)
Advances in peripheral T cell lymphoma
YL Kwong (Hong Kong) (20 min)
NK/T Cell Lymphoma
Weili Zhao (China) (20 min)
Angio-Immunoblastic T Cell Lymphoma
Daryl Tan (Singapore) (20 min)
Dr Surapol Issaragrisil (President, APHCON); Dr Richard Champlin; Dr. Wichai Prayoonwiwat (President, Thai Society Hematology)
8:30 AM: B-CELL LYMPHOMA
Moderator: Surapol Issaragrisil (Thailand); Richard Champlin (USA)
Revised Classification, New Diagnostic Criteria for Non Hodgkin's Lymphoma
Pei Lin (USA) (20 min)
Allogeneic Stem Cell transplantation for Lymphoma (includes Hodgkin's Lymphoma)
Didier Blaise (France) (30 min)
Antibodies, Protein Inhibitors and CAR-T Updates from ASH 2016
Frederick Hagemeister (USA) (30 min)
10:00 AM: Coffee Break and Poster viewing
10:30 AM: T-CELL LYMPHOMA
Moderator: Wichai Prayoonwiwat (Thailand), Adolfo de la Fuente (Spain)
Advances in peripheral T cell lymphoma
YL Kwong (Hong Kong) (20 min)
NK/T Cell Lymphoma
Weili Zhao (China) (20 min)
Angio-Immunoblastic T Cell Lymphoma
Daryl Tan (Singapore) (20 min)
12:00 PM LUNCH
1:00 PM Hodgkin's Lymphoma
Moderator: Noppadol Siritanaratkul (Thailand), Frederick Hagemeister (USA)
Newly Diagnosed HL
Adolfo de la Fuente (Spain) (15 min)
PET Monitoring for Response and Therapy Decisions
Pankaj Malhotra (India) (15 min)
PD-1 Inhibition Studies at ASH 2016
Frederick Hagemeister (USA) (15 min)
Moderator: Noppadol Siritanaratkul (Thailand), Frederick Hagemeister (USA)
Newly Diagnosed HL
Adolfo de la Fuente (Spain) (15 min)
PET Monitoring for Response and Therapy Decisions
Pankaj Malhotra (India) (15 min)
PD-1 Inhibition Studies at ASH 2016
Frederick Hagemeister (USA) (15 min)
2:00 PM Diffuse Large B Cell Lymphoma
Moderator: Suporn Chuncharunee (Thailand), Govind Babu (India)
Therapy for Newly Diagnosed DLBCL: More Than R-CHOP?
Fredrick Hagemeister (USA) (15 min)
Approach to Primary Treatment Failure in DLBCL
Archrob Khuhapinant (Thailand) (15 min)
Management of CNS Involvement in DLBCL
Govind Babu (India) (15 min)
Moderator: Suporn Chuncharunee (Thailand), Govind Babu (India)
Therapy for Newly Diagnosed DLBCL: More Than R-CHOP?
Fredrick Hagemeister (USA) (15 min)
Approach to Primary Treatment Failure in DLBCL
Archrob Khuhapinant (Thailand) (15 min)
Management of CNS Involvement in DLBCL
Govind Babu (India) (15 min)
3:00 PM - 3:30 PM COFFEE BREAK
3:30 PM Low Grade Lymphoma
Moderator: Wanchai Wanachiwanawin (Thailand), Daryl Tan (Singapore)
Newly Diagnosed Follicular Lymphoma: Chemo- vs. Targeted Therapy?
Daryl Tan (Singapore) (15 min)
MRD and Maintenance Therapy for FL
Ashok Vaid (India) (15 min)
Stem Cell Transplant for FL
Adolfo de la Fuente (Spain) (15 min)
Newly Diagnosed Mantle Cell Lymphoma
Hui Qiang Huang (China) (15 min)
Moderator: Wanchai Wanachiwanawin (Thailand), Daryl Tan (Singapore)
Newly Diagnosed Follicular Lymphoma: Chemo- vs. Targeted Therapy?
Daryl Tan (Singapore) (15 min)
MRD and Maintenance Therapy for FL
Ashok Vaid (India) (15 min)
Stem Cell Transplant for FL
Adolfo de la Fuente (Spain) (15 min)
Newly Diagnosed Mantle Cell Lymphoma
Hui Qiang Huang (China) (15 min)
4:30 PM Chronic Lymphocytic Leukemia
Moderator: Ponlapat Rojnuckarin (Thailand), Raymond Wong (Hong Kong)
Novel Targeted Therapies for CLL
Colin Phipps (Singapore) (15 min)
Therapy for CLL: Advances and Challenges
Frederick Hagemeister (USA) (15 min)
Maintenance Therapy in CLL
Raymond Wong (Hong Kong) (15 min)
Moderator: Ponlapat Rojnuckarin (Thailand), Raymond Wong (Hong Kong)
Novel Targeted Therapies for CLL
Colin Phipps (Singapore) (15 min)
Therapy for CLL: Advances and Challenges
Frederick Hagemeister (USA) (15 min)
Maintenance Therapy in CLL
Raymond Wong (Hong Kong) (15 min)
5:30 PM ADJOURN
DAY 2: JAN 13, 2017
8:00 AM Acute Myeloid Leukemia
Moderator: Borje Andersson (USA) and Kaiyan Liu (China)
Ideal Induction Therapy for Newly Diagnosed AML. Do We Have A Consensus?
Jie Jin (China) (20 min)
Decision Analysis of Post Remission Therapy for Intermediate Risk AML
Kanadit Prayongratana (20 min)
Allogeneic Stem Cell Transplant in CR1 for t(8;21) AML
Xiao Jun Huang (China) (20 min)
Cord Blood Derived WT1 Dendritic Vaccine for AML
Jaap Jan Boelens (Netherlands) (20 min)
Advances in Treatment for Elderly AML
William Hwang (Singapore) (20 min)
10:00 AM Kian Ang Memorial Lecture
Moderator: Borje Andersson (USA) and Panya Seksan (Thailand)
Towards Predictable Immune-Reconstitution after Allogeneic Stem Cell Transplant. Are We There Yet?
Jaap Jan Boelens (Netherlands) (25 min)
10:30 AM Coffee Break and poster Session
10:50 AM Acute Lymphocytic Lymphoma
Moderator: Xiao Jun Huang (China) and William Hwang (Singapore)
Early T Precursor Acute Lymphoblastic Leukemia
Joseph Khoury (USA) (20 min)
CAR19 - T Cell Adoptive Therapy for B-ALL
Xiao Jun Huang (China) (20 min)
Personalized Therapy in Pediatric ALL
Allen Yeoh (Singapore) (20 min)
Update on Allogeneic Stem Cell Transplant in ALL
Jaap Jan Boelens (Netherlands)(20 min)
Moderator: Borje Andersson (USA) and Kaiyan Liu (China)
Ideal Induction Therapy for Newly Diagnosed AML. Do We Have A Consensus?
Jie Jin (China) (20 min)
Decision Analysis of Post Remission Therapy for Intermediate Risk AML
Kanadit Prayongratana (20 min)
Allogeneic Stem Cell Transplant in CR1 for t(8;21) AML
Xiao Jun Huang (China) (20 min)
Cord Blood Derived WT1 Dendritic Vaccine for AML
Jaap Jan Boelens (Netherlands) (20 min)
Advances in Treatment for Elderly AML
William Hwang (Singapore) (20 min)
10:00 AM Kian Ang Memorial Lecture
Moderator: Borje Andersson (USA) and Panya Seksan (Thailand)
Towards Predictable Immune-Reconstitution after Allogeneic Stem Cell Transplant. Are We There Yet?
Jaap Jan Boelens (Netherlands) (25 min)
10:30 AM Coffee Break and poster Session
10:50 AM Acute Lymphocytic Lymphoma
Moderator: Xiao Jun Huang (China) and William Hwang (Singapore)
Early T Precursor Acute Lymphoblastic Leukemia
Joseph Khoury (USA) (20 min)
CAR19 - T Cell Adoptive Therapy for B-ALL
Xiao Jun Huang (China) (20 min)
Personalized Therapy in Pediatric ALL
Allen Yeoh (Singapore) (20 min)
Update on Allogeneic Stem Cell Transplant in ALL
Jaap Jan Boelens (Netherlands)(20 min)
12:30 PM LUNCH
|
1:00 PM Aplastic Anemia
Moderator Surapol Issaragrisil (Thailand) and Pankaj Malhotra (India) Non transplant Therapies Suporn Chuncharunee (Thailand) (15 min) Donor Selection and Conditioning Regimen Richard Champlin (USA) (15 min) Case Discussion (15 min) 2:00 PM Thalassemia
Moderator Suradej Hongeng (Thailand) and Borje Andersson (USA) Iron Overload and Novel Therapy Vip Viprakasit (Thailand) (15 min) Transplant Updates Suradej Hongeng (Thailand) (15 min) Case Discussion (15 min) |
1:00 PM Acute Myeloid Leukemia
Moderator Artit Ungkanont (Thailand) and Weili Zhao (China) Determining and Monitoring MRD Pei Lin (USA) (15 min) Biphenotypic AML Suning Chen (China) (15 min) FLT3 Positive AML Vikram Mathews (India) (15 min) 2:00 PM Chronic Myelogenous Leukemia
Moderator Tontanai Numbenjapol (Thailand) and Eakkapol Utchariyaprasit (Thailand) Novel Concepts in Myeloid Neoplasms: Lessons Learned from Chronic Myelomonocytic Leukemia Joseph Khoury (USA) (15 min) Newly Diagnosed CML Qiang Jiang (China) (15 min) Relapsed CML Dong Wook Kim (S. Korea) (15 min) Allogeneic Stem Cell Transplant and NK Cell Therapy Richard Champlin (USA) (15 min) |
3:00 PM - 3:15 PM COFFEE BREAK
|
3:15 PM Immune Thrombocytopenia
Moderator Theera Ruchutrakool (Thailand) and Pankaj Malhotra (India) How to Treat Newly diagnosed ITP Raymond Wong (Hong Kong) (15 min) Treatment of Relapsed/ Refractory ITP Ponlapat Rojnuckarin (Thailand) (15 min) Thrombocytopenic Syndrome in Pregnancy Theera Ruchutrakool (Thailand) (15 min) 4:15 PM Hemophilia
Moderator Ampaiwan Chuansumrit (Thailand) and Vikram Mathews (India) Standard of Care and Assessment for Hemophilia Ampaiwan Chuansumrit (Thailand) (15 min) Novel Treatment using Emcizumab Keiji Nogami (Japan) (15 min) Genetic Mutations in Hemophilia Objoon Trachoo (Thailand) (15 min) |
3:15 PM Donor selection
Moderator Piyanuch Kongtim (Thailand), and Richard Champlin (USA) Haplo vs. MUD Borje S. Andersson (USA) (15 min) Haplo vs. Cord Didier Blaise (France) (15 min) Managing Donor HLA Antibodies Piyanuch Kongtim (Thailand) (15 min) 4:15 PM Graft versus Host Disease
Moderator Udomsak Bunworasate (Thailand) and Suning Chen (China) Post-Transplant Cy vs. ATG for Haplo Transplant Didier Blaise (France) (15 min) Risk Stratified Corticosteroids for Haplo Transplant Xiao Jun Huang (China) (15 min) Cell Therapy for GVHD Jaap Jan Boelens (Netherlands) (15 min) |
5:30 PM APHCON PRESIDENT DINNER RECEPTION
(For Faculty Only)
(For Faculty Only)
DAY 3: JAN 14, 2017
8:00 AM MULTIPLE MYELOMA: NEWLY DIAGNOSED
(Open forum with interactive Q and A session)
Moderator Robert Orlowski (USA), Lalita Norasetthada (Thailand)
Consensus Guidelines for Diagnosis and Response.
Elisabet Esteve Manasanch (USA) (20 min)
Frontline Therapy for Transplant Eligible Patients: Doublet, Triptlet, Quadruplet.
Robert Orlowski (USA) (20 min)
Autologous Stem Cell Transplant and Post-Transplant maintenance
Simrit Parmar (USA) (20 min)
Frontline Therapy for Transplant In-eligible patients.
Juan Li (China) (20 min)
9:30 AM COFFEE BREAK
10:00 AM MULTIPLE MYELOMA: RELAPSED
Moderator James CS Chim (Hong Kong), Weerasak Nawarawong (Thailand)
Defining Relapse: Biochemical vs. symptomatic. When to Increase the Dose? When to Switch Therapy?
Elisabet Esteve Manasanch (USA) (20 min)
Choice of Therapy for Relapsed Myeloma.
James CS Chim (Hong Kong) (20 min)
Changing Landscape of Myeloma Therapy: Focus on Proteasome Inhibitors.
Robert Orlowski (USA) (20 min)
Changing Landscape of Myeloma Therapy: Focus on Immunotherapy
Elisabet Esteve Manasanch (USA) (20 min)
Changing Landscape of Myeloma Therapy: Focus on Cell Therapy
Richard Champlin (USA) (20 min)
Management of Non-Secretory Myeloma
Jin Lu (China) (20 min)
Management of Bone Disease in Myeloma
Robert Orlowski (USA) (20 min)
12:30 PM LUNCH SESSION
2:00 PM ADJOURN
(Open forum with interactive Q and A session)
Moderator Robert Orlowski (USA), Lalita Norasetthada (Thailand)
Consensus Guidelines for Diagnosis and Response.
Elisabet Esteve Manasanch (USA) (20 min)
Frontline Therapy for Transplant Eligible Patients: Doublet, Triptlet, Quadruplet.
Robert Orlowski (USA) (20 min)
Autologous Stem Cell Transplant and Post-Transplant maintenance
Simrit Parmar (USA) (20 min)
Frontline Therapy for Transplant In-eligible patients.
Juan Li (China) (20 min)
9:30 AM COFFEE BREAK
10:00 AM MULTIPLE MYELOMA: RELAPSED
Moderator James CS Chim (Hong Kong), Weerasak Nawarawong (Thailand)
Defining Relapse: Biochemical vs. symptomatic. When to Increase the Dose? When to Switch Therapy?
Elisabet Esteve Manasanch (USA) (20 min)
Choice of Therapy for Relapsed Myeloma.
James CS Chim (Hong Kong) (20 min)
Changing Landscape of Myeloma Therapy: Focus on Proteasome Inhibitors.
Robert Orlowski (USA) (20 min)
Changing Landscape of Myeloma Therapy: Focus on Immunotherapy
Elisabet Esteve Manasanch (USA) (20 min)
Changing Landscape of Myeloma Therapy: Focus on Cell Therapy
Richard Champlin (USA) (20 min)
Management of Non-Secretory Myeloma
Jin Lu (China) (20 min)
Management of Bone Disease in Myeloma
Robert Orlowski (USA) (20 min)
12:30 PM LUNCH SESSION
2:00 PM ADJOURN